ARTICLE | Clinical News
SRF231: Preclinical data
November 18, 2016 6:32 PM UTC
In a mouse xenograft model of lymphoma, SRF231 plus Rituxan rituximab led to a greater reduction in tumor volume vs. Rituxan alone. Data were presented at the Society for Immunotherapy of Cancer meeti...
BCIQ Company Profiles
BCIQ Target Profiles